Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study.

Servais S, Baron F, Lechanteur C, Seidel L, Selleslag D, Maertens J, Baudoux E, Zachee P, Van Gelder M, Noens L, Kerre T, Lewalle P, Schroyens W, Ory A, Beguin Y.

Oncotarget. 2018 Apr 17;9(29):20590-20604. doi: 10.18632/oncotarget.25020. eCollection 2018 Apr 17.

2.

Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey.

Devos T, Beguin Y, Noens L, Van Eygen K, Zachée P, Mineur P, Knoops L, Doyen C, Theunissen K, Benghiat FS, Reusens M, Pluymers W.

Eur J Haematol. 2018 Apr;100(4):361-366. doi: 10.1111/ejh.13022. Epub 2018 Feb 7.

3.

Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials.

Schlenk RF, Krauter J, Raffoux E, Kreuzer KA, Schaich M, Noens L, Pabst T, Vusirikala M, Bouscary D, Spencer A, Candoni A, Gil JS, Berkowitz N, Weber HJ, Ottmann O.

Haematologica. 2018 Jan;103(1):e25-e28. doi: 10.3324/haematol.2017.172411. Epub 2017 Oct 19. No abstract available.

4.

International, prospective haemovigilance study on methylene blue-treated plasma.

Noens L, Vilariño MD, Megalou A, Qureshi H.

Vox Sang. 2017 May;112(4):352-359. doi: 10.1111/vox.12510. Epub 2017 Mar 26.

PMID:
28345172
5.

Hand grip strength as a screening tool for frailty in older patients with haematological malignancies.

Velghe A, De Buyser S, Noens L, Demuynck R, Petrovic M.

Acta Clin Belg. 2016 Aug;71(4):227-30. doi: 10.1080/17843286.2016.1162381. Epub 2016 Apr 27.

PMID:
27118256
6.

Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma.

Dutoit JC, Claus E, Offner F, Noens L, Delanghe J, Verstraete KL.

Eur J Radiol. 2016 Feb;85(2):373-82. doi: 10.1016/j.ejrad.2015.11.040. Epub 2015 Dec 2.

PMID:
26781143
7.

Correction: Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification.

Duyvejonck H, Cools P, Decruyenaere J, Roelens K, Noens L, Vermeulen S, Claeys G, Decat E, Van Mechelen E, Vaneechoutte M.

PLoS One. 2015 Sep 25;10(9):e0139501. doi: 10.1371/journal.pone.0139501. eCollection 2015. No abstract available.

8.

Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification.

Duyvejonck H, Cools P, Decruyenaere J, Roelens K, Noens L, Vermeulen S, Claeys G, Decat E, Van Mechelen E, Vaneechoutte M.

PLoS One. 2015 Aug 21;10(8):e0132149. doi: 10.1371/journal.pone.0132149. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0139501.

9.

Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey.

Beguin Y, Selleslag D, Meers S, Graux C, Bries G, Deeren D, Vrelust I, Ravoet C, Theunissen K, Voelter V, Potier H, Trullemans F, Noens L, Mineur P.

Acta Clin Belg. 2015 Feb;70(1):34-43. doi: 10.1179/2295333714Y.0000000102. Epub 2014 Dec 2.

10.

Myelofibrosis patients in Belgium: disease characteristics.

Devos T, Zachée P, Bron D, Noens L, Droogenbroeck JV, Mineur P, Beguin Y, Berneman Z, Benghiat FS, Kentos A, Chatelain C, Demuynck H, Lemmens J, Eygen KV, Theunissen K, Trullemans F, Pierre P, Pluymers W, Knoops L.

Acta Clin Belg. 2015 Apr;70(2):105-11. doi: 10.1179/2295333714Y.0000000097. Epub 2014 Nov 6.

11.

Plerixafor prescription modalities in autologous haematopoietic stem cell mobilization in Belgium.

Selleslag D, Lambert C, Zachee P, Huyngh P, Van de Velde A, Noens L, Baily L, André M, Willems E, Dierickx D.

Acta Clin Belg. 2015 Feb;70(1):16-22. doi: 10.1179/2295333714Y.0000000077. Epub 2014 Sep 18.

PMID:
25236359
12.

Validation of the G8 screening tool in older patients with aggressive haematological malignancies.

Velghe A, Petrovic M, De Buyser S, Demuynck R, Noens L.

Eur J Oncol Nurs. 2014 Dec;18(6):645-8. doi: 10.1016/j.ejon.2014.05.006. Epub 2014 Jun 20.

PMID:
24954768
13.

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.

Delforge M, Selleslag D, Beguin Y, Triffet A, Mineur P, Theunissen K, Graux C, Trullemans F, Boulet D, Van Eygen K, Noens L, Van Steenweghen S, Lemmens J, Pierre P, D'hondt R, Ferrant A, Deeren D, Van De Velde A, Wynendaele W, André M, De Bock R, Efira A, Breems D, Deweweire A, Geldhof K, Pluymers W, Harrington A, MacDonald K, Abraham I, Ravoet C.

Leuk Res. 2014 May;38(5):557-63. doi: 10.1016/j.leukres.2014.02.003. Epub 2014 Feb 14.

PMID:
24661630
14.

Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges.

Noens L, Hensen M, Kucmin-Bemelmans I, Lofgren C, Gilloteau I, Vrijens B.

Haematologica. 2014 Mar;99(3):437-47. doi: 10.3324/haematol.2012.082511. Review.

15.

Management of myelodysplastic syndromes in adults: guidelines from the Belgian Haematological Society.

Meers S, Breems D, Bries G, Delforge M, Graux C, Ravoet C, Selleslag D, Noens L; Belgian Haematological Society.

Acta Clin Belg. 2013 Jul-Aug;68(4):253-62.

PMID:
24455794
16.

Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma.

Thomas SK, Suvorov A, Noens L, Rukavitsin O, Fay J, Wu KL, Zimmerman TM, van de Velde H, Bandekar R, Puchalski TA, Qi M, Uhlar C, Samoylova OS.

Cancer Chemother Pharmacol. 2014 Jan;73(1):35-42. doi: 10.1007/s00280-013-2314-7. Epub 2013 Oct 23.

PMID:
24149943
17.

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.

Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni A, Noens L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F.

Qual Life Res. 2014 Apr;23(3):825-36. doi: 10.1007/s11136-013-0523-5. Epub 2013 Sep 13.

PMID:
24026634
18.

Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study.

Oeyen SG, Benoit DD, Annemans L, Depuydt PO, Van Belle SJ, Troisi RI, Noens LA, Pattyn P, Decruyenaere JM.

Intensive Care Med. 2013 May;39(5):889-98. doi: 10.1007/s00134-012-2791-x. Epub 2012 Dec 18.

PMID:
23248039
19.

Early recognition of malignant lactic acidosis in clinical practice: report on 6 patients with haematological malignancies.

De Raes EA, Benoit DD, Depuydt PO, Offner F, Nollet J, Vantilborgh AK, Steel E, Noens LA, Decruyenaere JM.

Acta Clin Belg. 2012 Sep-Oct;67(5):347-51.

PMID:
23189542
20.

Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.

Lugtenburg P, Silvestre AS, Rossi FG, Noens L, Krall W, Bendall K, Szabo Z, Jaeger U.

Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):297-305. doi: 10.1016/j.clml.2012.06.004.

PMID:
23040435
21.

High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.

Janssens A, Van Roy N, Poppe B, Noens L, Philippé J, Speleman F, Offner F.

Eur J Haematol. 2012 Jul;89(1):72-80. doi: 10.1111/j.1600-0609.2012.01790.x. Epub 2012 May 7.

PMID:
22509718
22.

Savene® (dexrazoxane) use in clinical practice.

Fontaine C, Noens L, Pierre P, De Grève J.

Support Care Cancer. 2012 May;20(5):1109-12. doi: 10.1007/s00520-012-1382-2. Epub 2012 Jan 27.

PMID:
22278308
23.

Geriatrics and haematological malignancies: is comprehensive geriatric assessment a useful tool?

Noens L.

Eur J Cancer. 2011 Sep;47 Suppl 3:S362-3. doi: 10.1016/S0959-8049(11)70204-0. Review. No abstract available.

PMID:
21944016
24.

High dose chemotherapy and stem cell rescue for metastatic germ cell tumours: long-term results from a single institution.

Kruse V, Noens L, Lumen N, Hoebeke P, Van Belle S, Rottey S.

Acta Clin Belg. 2011 Jul-Aug;66(4):254-9.

PMID:
21938979
25.

EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells.

De Weer A, Van der Meulen J, Rondou P, Taghon T, Konrad TA, De Preter K, Mestdagh P, Van Maerken T, Van Roy N, Jeison M, Yaniv I, Cauwelier B, Noens L, Poirel HA, Vandenberghe P, Lambert F, De Paepe A, Sánchez MG, Odero M, Verhasselt B, Philippé J, Vandesompele J, Wieser R, Dastugue N, Van Vlierberghe P, Poppe B, Speleman F.

Br J Haematol. 2011 Aug;154(3):337-48. doi: 10.1111/j.1365-2141.2011.08737.x. Epub 2011 May 14.

PMID:
21569010
26.

Aspiration pneumonia: an underestimated cause of severe respiratory failure in patients with haematological malignancies and severe oral mucositis?

De Neve NY, Benoit DD, Depuydt PO, Offner FC, Nollet J, Noens LA, Decruyenaere JM.

Acta Clin Belg. 2010 Nov-Dec;65(6):416-9.

PMID:
21268956
27.

Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience.

Depuydt P, Kerre T, Noens L, Nollet J, Offner F, Decruyenaere J, Benoit D.

Bone Marrow Transplant. 2011 Sep;46(9):1186-91. doi: 10.1038/bmt.2010.255. Epub 2010 Nov 1.

PMID:
21042315
28.

Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study.

Van Calsteren K, Verbesselt R, Ottevanger N, Halaska M, Heyns L, Van Bree R, de Bruijn E, Chai D, Delforge M, Noens L, Renard V, Witteveen E, Rob L, de Hoon J, Amant F.

Acta Obstet Gynecol Scand. 2010 Oct;89(10):1338-45. doi: 10.3109/00016349.2010.512070.

PMID:
20846067
29.

Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies.

Vandijck DM, Depuydt PO, Offner FC, Nollet J, Peleman RA, Steel E, Noens LA, Decruyenaere JM, Benoit DD.

Intensive Care Med. 2010 Oct;36(10):1744-50. doi: 10.1007/s00134-010-1903-8. Epub 2010 May 18.

PMID:
20480137
30.

Identification of two critically deleted regions within chromosome segment 7q35-q36 in EVI1 deregulated myeloid leukemia cell lines.

De Weer A, Poppe B, Vergult S, Van Vlierberghe P, Petrick M, De Bock R, Benoit Y, Noens L, De Paepe A, Van Roy N, Menten B, Speleman F.

PLoS One. 2010 Jan 13;5(1):e8676. doi: 10.1371/journal.pone.0008676.

31.

The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure.

Depuydt PO, Benoit DD, Roosens CD, Offner FC, Noens LA, Decruyenaere JM.

J Crit Care. 2010 Mar;25(1):30-6. doi: 10.1016/j.jcrc.2009.02.016. Epub 2009 Aug 13.

PMID:
19682849
32.

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.

Noens L, van Lierde MA, De Bock R, Verhoef G, Zachée P, Berneman Z, Martiat P, Mineur P, Van Eygen K, MacDonald K, De Geest S, Albrecht T, Abraham I.

Blood. 2009 May 28;113(22):5401-11. doi: 10.1182/blood-2008-12-196543. Epub 2009 Apr 6.

PMID:
19349618
33.

Guidelines for the transfusion of red cells.

Baele PL, Muylle L, Noens L, Gulliksson H, Brands A, Isbister J, Van der Linden P, Hübner R, Berneman Z, Lamy M, Ferrant A, Lambermont M, Sondag D.

Acta Clin Belg. 2008 Sep-Oct;63(5):301-12.

34.

EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22.

De Weer A, Speleman F, Cauwelier B, Van Roy N, Yigit N, Verhasselt B, De Moerloose B, Benoit Y, Noens L, Selleslag D, Lippert E, Struski S, Bastard C, De Paepe A, Vandenberghe P, Hagemeijer A, Dastugue N, Poppe B; Groupe Français de Cytogénétique Hématologique (GFCH).

Haematologica. 2008 Dec;93(12):1903-7. doi: 10.3324/haematol.13192. Epub 2008 Sep 24.

35.

Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.

Vandijck DM, Benoit DD, Depuydt PO, Offner FC, Blot SI, Van Tilborgh AK, Nollet J, Steel E, Noens LA, Decruyenaere JM.

Intensive Care Med. 2008 May;34(5):847-55. doi: 10.1007/s00134-008-1002-2. Epub 2008 Jan 24.

PMID:
18214437
36.

Guidelines for the transfusion of platelets.

Bosly A, Muylle L, Noens L, Pietersz R, Heims D, Hübner R, Selleslag D, Toungouz M, Ferrant A, Sondag D.

Acta Clin Belg. 2007 Jan-Feb;62(1):36-47. Review.

PMID:
17451144
37.

Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion.

Donckier V, Troisi R, Le Moine A, Toungouz M, Ricciardi S, Colle I, Van Vlierberghe H, Craciun L, Libin M, Praet M, Noens L, Stordeur P, Andrien M, Lambermont M, Gelin M, Bourgeois N, Adler M, de Hemptinne B, Goldman M.

Liver Transpl. 2006 Oct;12(10):1523-8.

38.

Focally enhanced f-18 fluorodeoxyglucose (FDG) uptake in incidentally detected pulmonary embolism on PET/CT scanning.

Goethals I, Smeets P, De Winter O, Noens L.

Clin Nucl Med. 2006 Aug;31(8):497-8. No abstract available.

PMID:
16855443
39.

EBV negative Richter's syndrome from a coexistent clone after salvage treatment with alemtuzumab in a CLL patient.

Janssens A, Berth M, De Paepe P, Verhasselt B, Van Roy N, Noens L, Philippé J, Offner F.

Am J Hematol. 2006 Sep;81(9):706-12.

40.

In utero exposure to chemotherapy: effect on cardiac and neurologic outcome.

Van Calsteren K, Berteloot P, Hanssens M, Vergote I, Amant F, Ganame J, Claus P, Mertens L, Lagae L, Delforge M, Paridaens R, Noens L, Humblet Y, Vandermeersch B, De Muylder X.

J Clin Oncol. 2006 Apr 20;24(12):e16-7. No abstract available.

PMID:
16622256
41.

ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy.

Troisi R, Noens L, Montalti R, Ricciardi S, Philippé J, Praet M, Conoscitore P, Centra M, de Hemptinne B.

Liver Transpl. 2006 Sep;12(9):1412-7.

42.

Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia.

Heil G, Hoelzer D, Sanz MA, Lechner K, Noens L, Szer J, Ganser A, Matcham J, Renwick J; International Acute Myeloid Leukemia Study Group.

Leukemia. 2006 Mar;20(3):404-9.

PMID:
16424872
43.

Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.

Benoit DD, Depuydt PO, Vandewoude KH, Offner FC, Boterberg T, De Cock CA, Noens LA, Janssens AM, Decruyenaere JM.

Intensive Care Med. 2006 Jan;32(1):93-9. Epub 2005 Nov 25.

PMID:
16308681
44.

Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome.

Benoit DD, Depuydt PO, Peleman RA, Offner FC, Vandewoude KH, Vogelaers DP, Blot SI, Noens LA, Colardyn FA, Decruyenaere JM.

Intensive Care Med. 2005 Jul;31(7):934-42. Epub 2005 Mar 22.

PMID:
15782316
45.

Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies.

Benoit DD, Hoste EA, Depuydt PO, Offner FC, Lameire NH, Vandewoude KH, Dhondt AW, Noens LA, Decruyenaere JM.

Nephrol Dial Transplant. 2005 Mar;20(3):552-8. Epub 2005 Jan 25.

PMID:
15671075
46.

Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia.

Swerts K, de Moerloose B, Dhooge C, Noens L, Laureys G, Benoit Y, Philippé J.

Leuk Lymphoma. 2004 Nov;45(11):2221-8.

PMID:
15512810
47.

Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.

Donckier V, Troisi R, Toungouz M, Colle I, Van Vlierberghe H, Jacquy C, Martiat P, Stordeur P, Zhou L, Boon N, Lambermont M, Schandené L, Van Laethem JL, Noens L, Gelin M, de Hemptinne B, Goldman M.

Transpl Immunol. 2004 Sep-Oct;13(2):139-46.

PMID:
15380544
48.

Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trial.

Heil G, Krauter J, Raghavachar A, Bergmann L, Hoelzer D, Fiedler W, Lübbert M, Noens L, Schlimok G, Arnold R, Kirchner H, Ganser A.

Ann Hematol. 2004 Jun;83(6):336-44. Epub 2004 Mar 18.

PMID:
15034758
49.

18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients.

Van Den Bossche B, Lambert B, De Winter F, Kolindou A, Dierckx RA, Noens L, Van De Wiele C.

Nucl Med Commun. 2002 Nov;23(11):1079-83.

PMID:
12411836
50.

Repeated isolation of Cryptococcus laurentii from the oropharynx of an immunocompromized patient.

Bauters TG, Swinne D, Boekhout T, Noens L, Nelis HJ.

Mycopathologia. 2002;153(3):133-5.

PMID:
11998874

Supplemental Content

Support Center